何苗, 程宏文. 替吉奥联合奥沙利铂治疗晚期结直肠癌的疗效观察[J]. 实用临床医药杂志, 2011, (17): 110-112. DOI: 10.3969/j.issn.1672-2353.2011.17.039
引用本文: 何苗, 程宏文. 替吉奥联合奥沙利铂治疗晚期结直肠癌的疗效观察[J]. 实用临床医药杂志, 2011, (17): 110-112. DOI: 10.3969/j.issn.1672-2353.2011.17.039
HE Miao, CHENG Hong-wen. The therapeutic effect of compound Tegafur capsules plus Oxaliplatin for the treatment of advanced colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2011, (17): 110-112. DOI: 10.3969/j.issn.1672-2353.2011.17.039
Citation: HE Miao, CHENG Hong-wen. The therapeutic effect of compound Tegafur capsules plus Oxaliplatin for the treatment of advanced colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2011, (17): 110-112. DOI: 10.3969/j.issn.1672-2353.2011.17.039

替吉奥联合奥沙利铂治疗晚期结直肠癌的疗效观察

The therapeutic effect of compound Tegafur capsules plus Oxaliplatin for the treatment of advanced colorectal cancer

  • 摘要: 目的 评价替吉奥胶囊联合奥沙利铂治疗晚期结直肠癌的近期疗效及毒副反应.方法 52例晚期结直肠癌患者采用替吉奥联合奥沙利铂治疗,替吉奥胶囊80 mg/(m2?d),分2次餐后口服,dt~14.奥沙利铂130 mg/m2,静脉滴注,滴注时间3~6 h,d1.4周为1个周期.治疗3周期评价疗效.结果 52例患者总有效率为48.1%.完全缓解(CR)2例,占全部患者的3.8%;部分缓解(PR) 23例,44.2%;稳定(SD) 18例,34.6%;进展(PD)9例,17.3%.主要毒副作用为消化道反应、骨髓抑制,末梢神经炎等,无患者死亡.结论 替吉奥胶囊联合奥沙利铂治疗晚期结直肠癌疗效好,毒副作用相对较低,值得临床推广.

     

/

返回文章
返回